Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase NA 2Phase 2 1

Status

Completed 6Unknown 1

Sponsor Class

OTHER 9NIH 7

Study Type

Interventional 7

Sponsor

Cancer Type

Genitourinary 7

Conditions

Prostatic Neoplasms 7Prostatic Hyperplasia 1Neoplasms 1

Interventions

Docetaxel 26Prednisone 16Magnetic Resonance Spectroscopy 16Specimen Handling 15PROSTVAC 14Biopsy 12Goserelin 11bicalutamide 10Leuprolide 9sargramostim 8Estramustine 8Radiotherapy 7Lycopene 7High-Intensity Focused Ultrasound Ablation 7Flutamide 7Bevacizumab 7enzalutamide 6Thalidomide 6Mitoxantrone 62-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 6ixabepilone 5olaparib 4cediranib 4Tomography, X-Ray Computed 4Radiation 4Nivolumab 4Magnetic Resonance Imaging 4Androgen Antagonists 4Amplified Fragment Length Polymorphism Analysis 4temsirolimus 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
NIH × Prostatic Neoplasms × Lycopene × Clear all
NCT00450749 2019-12-18

Lycopene in Treating Patients Undergoing Radical Prostatectomy for Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
10 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT00450957 2015-04-15

Lycopene in Healthy Male Participants

National Cancer Institute (NCI)

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT00322114 2013-09-20

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase NA Unknown
150 enrolled
Genitourinary

Prostatic Neoplasms

NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

National Cancer Institute (NCI)

Phase NA Completed
120 enrolled
Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00006078 2013-06-26

Lycopene In Preventing of Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

NCT00093561 2013-06-26

Lycopene in Preventing Prostate Cancer in Healthy Participants

National Cancer Institute (NCI)

Phase 1 Completed
Genitourinary

Prostatic Neoplasms

NCT00416325 2013-06-26

Lycopene in Preventing Prostate Cancer in Patients Who Are at High Risk of Developing Prostate Cancer

National Cancer Institute (NCI)

Phase 1 Completed
18 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡